ATE481406T1 - Pyrrolochinoxalinonderivate als antibakterielle mittel - Google Patents

Pyrrolochinoxalinonderivate als antibakterielle mittel

Info

Publication number
ATE481406T1
ATE481406T1 AT07727528T AT07727528T ATE481406T1 AT E481406 T1 ATE481406 T1 AT E481406T1 AT 07727528 T AT07727528 T AT 07727528T AT 07727528 T AT07727528 T AT 07727528T AT E481406 T1 ATE481406 T1 AT E481406T1
Authority
AT
Austria
Prior art keywords
pyrroloquinoxalinone
derivatives
antibacterial agents
antibacterial
agents
Prior art date
Application number
AT07727528T
Other languages
English (en)
Inventor
Graham Jones
Timothy Miles
Neil Pearson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0606970A external-priority patent/GB0606970D0/en
Priority claimed from GB0706023A external-priority patent/GB0706023D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE481406T1 publication Critical patent/ATE481406T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT07727528T 2006-04-06 2007-03-29 Pyrrolochinoxalinonderivate als antibakterielle mittel ATE481406T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0606970A GB0606970D0 (en) 2006-04-06 2006-04-06 Compounds
GB0706023A GB0706023D0 (en) 2007-03-26 2007-03-26 Compounds
PCT/EP2007/053056 WO2007115947A1 (en) 2006-04-06 2007-03-29 Pyrrolo-quinoxalinone derivatives as antibacterials

Publications (1)

Publication Number Publication Date
ATE481406T1 true ATE481406T1 (de) 2010-10-15

Family

ID=38580721

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07727528T ATE481406T1 (de) 2006-04-06 2007-03-29 Pyrrolochinoxalinonderivate als antibakterielle mittel

Country Status (9)

Country Link
US (1) US7709483B2 (de)
EP (1) EP2001887B1 (de)
JP (1) JP2009532423A (de)
AR (1) AR060287A1 (de)
AT (1) ATE481406T1 (de)
DE (1) DE602007009205D1 (de)
PE (1) PE20080182A1 (de)
TW (1) TW200815450A (de)
WO (1) WO2007115947A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1954697T1 (sl) * 2005-10-21 2010-05-31 Glaxo Group Ltd Peri kondenzirane triciklične spojine uporabne kot antibakterijska sredstva
ATE465163T1 (de) 2005-12-22 2010-05-15 Glaxo Group Ltd Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
GB0613208D0 (en) * 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
NZ579877A (en) * 2007-04-20 2011-09-30 Glaxo Group Ltd Tricyclic nitrogen containing compounds as antibacterial agents
NZ585529A (en) * 2007-11-26 2012-05-25 Toyama Chemical Co Ltd Novel naphthyridine derivative monohydrate and method for producing the same
EP2080761A1 (de) 2008-01-18 2009-07-22 Glaxo Group Limited Verbindungen
ES2411930T3 (es) 2008-02-20 2013-07-09 Actelion Pharmaceuticals Ltd. Compuestos antibióticos azatricíclicos
EP2300477A1 (de) * 2008-05-23 2011-03-30 Glaxo Group Limited Tricyclische, stickstoffhaltige verbindungen und ihre verwendung als antibakterielle mittel
JP5474941B2 (ja) * 2008-05-23 2014-04-16 グラクソ グループ リミテッド 窒素含有三環式化合物およびその抗菌剤としての使用
KR101294962B1 (ko) 2008-10-07 2013-08-12 액테리온 파마슈티칼 리미티드 트리사이클 옥사졸리디논 항생제 화합물
EP2352734A1 (de) 2008-10-17 2011-08-10 Glaxo Group Limited Als antibakterielle mittel verwendete tricyclische stickstoffverbindungen
CN102232078B (zh) 2008-12-12 2014-07-16 埃科特莱茵药品有限公司 5-氨基-2-(1-羟基-乙基)-四氢吡喃衍生物
WO2010081874A1 (en) 2009-01-15 2010-07-22 Glaxo Group Limited Naphthyridin-2 (1 h)-one compounds useful as antibacterials
CN101870653B (zh) * 2009-04-23 2013-07-10 上海合全药业有限公司 一种2-甲基-3-氟-6-硝基苯甲酸的合成方法
CA2958800C (en) 2014-08-22 2020-10-27 Glaxosmithkline Intellectual Property Development Limited Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection
CN111655690B (zh) 2017-11-24 2023-01-10 詹森药业有限公司 吡唑并吡啶酮化合物

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603199A (en) * 1982-10-25 1986-07-29 Riker Laboratories, Inc. Phenyl-substituted tricyclic antibacterial agent intermediates
JPS6084287A (ja) * 1983-10-14 1985-05-13 Nissan Chem Ind Ltd キノキザリノン誘導体，その製造法および農園芸用殺菌剤
FR2798656B1 (fr) 1999-09-17 2004-12-17 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
PL364808A1 (en) 2000-07-21 2004-12-13 Ljudmila Petrovna Maljuk Plate for a stand-up meal
NZ523749A (en) 2000-07-26 2005-03-24 Smithkline Beecham P Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
FR2816618B1 (fr) 2000-11-15 2002-12-27 Aventis Pharma Sa Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent
GB0031088D0 (en) 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
EP1345903A1 (de) 2000-12-21 2003-09-24 Ciba SC Holding AG Kristalline formen von cerivastatin-natrium
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
US7312212B2 (en) 2002-01-29 2007-12-25 Glaxo Group Limited Aminopiperidine derivatives
WO2003064431A2 (en) 2002-01-29 2003-08-07 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
GB0217294D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicaments
FR2844270B1 (fr) 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
FR2844268B1 (fr) 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
EP1551829B1 (de) 2002-10-10 2010-04-07 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Neue verbindungen mit antibakterieller aktivität
AU2003291227A1 (en) 2002-11-05 2004-06-07 Smithkline Beecham Corporation Antibacterial agents
ES2340484T3 (es) 2002-11-05 2010-06-04 Glaxo Group Limited Agentes antibacterianos.
AR042486A1 (es) 2002-12-18 2005-06-22 Glaxo Group Ltd Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion .
TW200507841A (en) 2003-03-27 2005-03-01 Glaxo Group Ltd Antibacterial agents
FR2852954B1 (fr) 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
DE10316081A1 (de) 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
WO2004104000A1 (ja) 2003-05-23 2004-12-02 Japan Tobacco Inc. トリサイクリック縮合環化合物およびその医薬用途
FR2858619B1 (fr) 2003-08-08 2006-12-22 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
FR2867472B1 (fr) 2004-03-12 2008-07-18 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
JP2008502689A (ja) 2004-06-15 2008-01-31 グラクソ　グループ　リミテッド 抗菌剤
FR2872164B1 (fr) 2004-06-29 2006-11-17 Aventis Pharma Sa Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
EP1773831A1 (de) * 2004-07-08 2007-04-18 Glaxo Group Limited Antibakterielle mittel
EP1773847A2 (de) 2004-07-09 2007-04-18 Glaxo Group Limited Antibakterielle mittel
JP2008506695A (ja) 2004-07-13 2008-03-06 グラクソ　グループ　リミテッド 抗細菌剤
JP2008507543A (ja) 2004-07-22 2008-03-13 グラクソ　グループ　リミテッド 抗細菌剤
JP2008508359A (ja) 2004-08-02 2008-03-21 グラクソ グループ リミテッド 抗菌剤
JP2008509222A (ja) 2004-08-09 2008-03-27 グラクソ グループ リミテッド 抗菌剤
DE102004041163A1 (de) 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
JP4887297B2 (ja) 2004-09-24 2012-02-29 アクテリオン ファーマシューティカルズ リミテッド 新規二環式抗生物質
DE602005021133D1 (de) 2004-10-05 2010-06-17 Actelion Pharmaceuticals Ltd Neue piperidin-antibiotika
WO2006046552A1 (ja) 2004-10-27 2006-05-04 Toyama Chemical Co., Ltd. 新規な含窒素複素環化合物およびその塩
JP2008528588A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
EP1846416A4 (de) 2005-01-25 2009-07-01 Glaxo Group Ltd Antibakterielle wirkstoffe
WO2006081264A1 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
EP1846411A4 (de) 2005-01-25 2010-08-04 Glaxo Group Ltd Antibakterielle wirkstoffe
EP1845995A4 (de) 2005-01-25 2010-03-03 Glaxo Group Ltd Antibakterielle wirkstoffe
WO2006099884A1 (en) 2005-03-24 2006-09-28 Actelion Percurex Ag Beta-aminoalcohol antibiotics
US7842810B2 (en) 2005-03-31 2010-11-30 Janssen Pharmaceutica, Nv Bicyclic pyrazole compounds as antibacterial agents
WO2006125974A1 (en) 2005-05-24 2006-11-30 Astrazeneca Ab Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
EP1888574B1 (de) 2005-05-25 2009-09-02 Actelion Pharmaceuticals Ltd. Neue antibiotische derivate
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
WO2006137485A1 (ja) 2005-06-24 2006-12-28 Toyama Chemical Co., Ltd. 新規な含窒素複素環化合物およびその塩
SI1954697T1 (sl) 2005-10-21 2010-05-31 Glaxo Group Ltd Peri kondenzirane triciklične spojine uporabne kot antibakterijska sredstva
ATE465163T1 (de) 2005-12-22 2010-05-15 Glaxo Group Ltd Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
GB0705672D0 (en) 2007-03-23 2007-05-02 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
US7709483B2 (en) 2010-05-04
JP2009532423A (ja) 2009-09-10
WO2007115947A1 (en) 2007-10-18
EP2001887B1 (de) 2010-09-15
US20090062265A1 (en) 2009-03-05
AR060287A1 (es) 2008-06-04
EP2001887A1 (de) 2008-12-17
DE602007009205D1 (de) 2010-10-28
TW200815450A (en) 2008-04-01
PE20080182A1 (es) 2008-05-01

Similar Documents

Publication Publication Date Title
DE602007009205D1 (de) Pyrrolochinoxalinonderivate als antibakterielle mittel
ATE460417T1 (de) Acetylenylpyrazolopyrimidinderivate als mglur2- antagonsten
BRPI0720220A2 (pt) Derivados de quinolinas antibacterianos
DK2054030T3 (da) Antimikrobielle midler
ATE443753T1 (de) Nuancierungsmittel
EP2050434A4 (de) Feuchtigkeitsspendendes mittel
DK2034997T3 (da) Antibakterielle sammensætninger
ATE475662T1 (de) Dihydropyrazolopyrimidinonderivate
ATE483711T1 (de) Spiroindolinonderivate
ATE469905T1 (de) Pyridopyrimidinonderivate
ATE512135T1 (de) Spiroindolinonderivate
DK2035394T3 (da) 2-pyrazincarboxamidderivater
EP2072519A4 (de) Diarylketiminderivat
DK1912647T3 (da) Quinolinderivater som antibakterielle midler
DK2086968T3 (da) 5-hydroxymethyl-oxazolidin-2-on-derivater
ATE451356T1 (de) Substituierte arylsulfonamide als antivirale mittel
FI20065388L (fi) Betuliiniperäiset yhdisteet antimikrobisina aineina
DE602007006553D1 (de) Antibakterielle chinolinderivate
DE602006010508D1 (de) Substituierte triazolderivate als oxytocinantagonisten
DK1901743T3 (da) Quinolinderivater som antibakterielle midler
DK1912648T3 (da) Quinolinderivater som antibakterielle midler
DK2099759T3 (da) Antibakterielle chinolinderivater
DE602007006231D1 (de) Antibakterielle chinolinderivate
DK2099760T3 (da) Antibakterielle quinolinderivater
EP2214719A4 (de) Metallofulleren-kontrastmittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties